Early Cranial Radiotherapy Enhances Survival in EGFR-Mutant NSCLC Patients
Research presented at the IASLC 2026 WCLC indicates that early cranial stereotactic radiotherapy combined with osimertinib improves outcomes for patients with EGFR-mutant NSCLC and limited…